Skip to main content


Hereditary Cancer Risk Assessment Program

  • Einstein Cancer Center provides genetic counseling for patients and family members through our Hereditary Cancer Risk Assessment Program.

    A predictive screening. The screenings are voluntary and help determine the likelihood of you developing cancer. They also help your oncology team determine how to treat your cancer or help to prevent/screen for other cancers in yourself and your family members.

    Who Should Get Screened

    We recommend genetic counseling for pediatric and adult patients who meet the following criteria:

    • A family history of cancer, such as three or more relatives on the same side of the family who have had the same or related cancer
    • Multiple cancers in the same person
    • Breast cancer occurrence when younger than 50 years old
    • Colon cancer occurrence when younger than 50 years old

    Make an Appointment

    Call genetic counselor Colleen Muraresku, MS, LCGC, at 215-456-4672

    When you schedule your appointment, a member of our staff will ask you for a personal or family history to determine where you will be screened.

    Locations and Hours

    Our genetic counselor offers special appointments for breast, ovarian and gastrointestinal cancer at specific locations. Risk assessments for other cancers, such as lung, adrenal, parathyroid, leukemia, sarcoma, and lymphoma are scheduled as available.

    Cancer Center at Einstein Medical Center Philadelphia
    5501 Old York Road
    Klein Building, Suite 101
    Philadelphia, PA 19141
    Get Directions
    Hours: Wednesday, from 9 a.m. – 12 p.m. for gastrointestinal cancer, including colon, rectal, uterine/endometrial, history of polyps, stomach, small bowel, adenal, pancreatic, kidney and ureter cancer, as well as ovarian cancer and endometrial (uterine) cancer.

    Marion-Louise Saltzman Women's Center at Einstein Medical Center Philadelphia
    5501 Old York Road
    Philadelphia, PA 19141
    Get Directions
    Hours: Monday and Thursday, from 9 a.m. – 3:30 p.m. and Friday, from 12 – 3:30 p.m. for breast and ovarian cancer. Either session can also allow for screening of fallopian tube, prostate, melanoma and pancreatic cancer.

    Center One
    9880 Bustleton Avenue
    Suite 205
    Philadelphia, PA 19115
    Get Directions
    Hours: The first and third Tuesday of the month, from 11 a.m. – 3:30 p.m.

    Initial Screening

    At the initial screening appointment, our genetic counselor will ask you for a brief history, which will involve providing information on your family history.

    Based on your history, our genetic counselor will discuss with the team of physicians to determine if genetic testing needs to be ordered. A vast majority of the testing is performed by a blood test, but some are also offered as a saliva test.

    We offer testing for a wide variety of hereditary cancer syndromes for individuals who are born with the syndromes instead of acquiring them through environmental factors and which may be passed down from your mother or father.

    Reviewing Your Results

    During your second appointment, our genetic counselor will discuss the results of your tests and connect you with cancer team members to discuss specific treatment or prevention methods. Based on your results, we will determine what additional follow-up may be necessary in genetics as advancements continue in testing.

    Learn more about genetic screenings at Einstein.


    Questions? Call Us:


    Accreditation & Partnerships

    Einstein Medical Center Philadelphia
    National Accreditation Program for Breast Centers

    Einstein Medical Center Philadelphia

    American Society for Radiation Oncology
    NCCCP medium

    Related Podcasts

    Colon Cancer
    Einstein doctors Donee Patterson and Richard Greenberg describe the test and risk factors for colon cancer, the most easily detected kind of cancer.

    Gynecological Cancer
    Know your body and seek help if you notice any changes in your reproductive health. Our physicians discuss symptoms and treatment options for gynecological cancer.